Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:52PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 329.26M |
| Enterprise value | 158.89M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.33 |
| Price/book (mrq) | 4.07 |
| Enterprise value/revenue | 1.13 |
| Enterprise value/EBITDA | -2.05 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.41 |
| 52-week change 3 | -84.08% |
| S&P500 52-week change 3 | -5.12% |
| 52-week high 3 | 25.0550 |
| 52-week low 3 | 2.9650 |
| 50-day moving average 3 | 5.7034 |
| 200-day moving average 3 | 7.0876 |
Share statistics
| Avg vol (3-month) 3 | 765.69k |
| Avg vol (10-day) 3 | 962.55k |
| Shares outstanding 5 | 92.23M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 69.55M |
| % held by insiders 1 | 9.01% |
| % held by institutions 1 | 83.81% |
| Shares short (28 Apr 2022) 4 | 4.99M |
| Short ratio (28 Apr 2022) 4 | 8.18 |
| Short % of float (28 Apr 2022) 4 | 8.89% |
| Short % of shares outstanding (28 Apr 2022) 4 | 5.41% |
| Shares short (prior month 30 Mar 2022) 4 | 4.63M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | -61.65% |
| Operating margin (ttm) | -60.35% |
Management effectiveness
| Return on assets (ttm) | -16.97% |
| Return on equity (ttm) | -77.22% |
Income statement
| Revenue (ttm) | 140.7M |
| Revenue per share (ttm) | 1.53 |
| Quarterly revenue growth (yoy) | -73.90% |
| Gross profit (ttm) | 3.04M |
| EBITDA | -78.88M |
| Net income avi to common (ttm) | -86.74M |
| Diluted EPS (ttm) | -0.9440 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 248M |
| Total cash per share (mrq) | 2.69 |
| Total debt (mrq) | 77.63M |
| Total debt/equity (mrq) | 95.89 |
| Current ratio (mrq) | 3.20 |
| Book value per share (mrq) | 0.88 |
Cash flow statement
| Operating cash flow (ttm) | -30.26M |
| Levered free cash flow (ttm) | -7.81M |
© 2022 Yahoo. All rights reserved.
